Currently viewing: What we do / Next: Our business model
We provide high quality, people-centred care throughout our diverse range of healthcare services across two major segments.
SOUTHERN AFRICA
| Total registered beds | 9 177 |
| Acute hospitals | 49 |
| Complementary services facilities | |
| Mental health facilities | 9 |
| Acute rehabilitation facilities | 7 |
| Renal dialysis stations | 433 |
| Oncology units | 5 |
| Life Employee Health Solutions (Life EHS) | |
| Occupational health clinics | 281 |
| Employee wellness clinics | 78 |
| Public Private Partnerships (PPPs) | |
| Life Esidimeni | 10 |
| Nursing Education | |
| Learning centres across SA | 7 |
UNITED KINGDOM AND EUROPE
| Operating sites/Mobiles | 231 |
| Cyclotron sites | 11 |
| No of scanners MRI/CT/PET-CT | 268 |
LIFE MOLECULAR IMAGING
| Manufacturing sites North America | 12 |
| Manufacturing sites Europe | 16 |
| Manufacturing sites Rest of the world | 10 |
| Ongoing and planned sites | 8 |
Southern Africa
In southern Africa, we strive to improve the lives of people through high-quality, cost-effective care offered through our hospital and healthcare services divisions.
Our hospital division includes acute hospitals in South Africa (SA) and Botswana, as well as complementary services comprising oncology, acute rehabilitation, renal dialysis and mental health.
Our healthcare services division provides specialised care offered by Life Esidimeni and occupational health and employee wellness services offered by Life Employee Health Solutions.
 |
For more on our southern African segment, refer to Southern African business review. |
International
Our international segment includes Alliance Medical Group (AMG) and Life Molecular Imaging (LMI).
AMG is one of the largest independent imaging providers in the United Kingdom (UK) and Europe.
LMI is a fully integrated research and development pharma company dedicated to developing and globally commercialising innovative molecular imaging agents for use in PET-CT diagnostics.
|
For more on our International segment, refer International business review. |